Pharma & Bio
Lifestyle
“Which of 100,000 AI-Generated New Drugs Are Legitimate?”…PROTEINA CO., LTD. Screens Candidate Compounds Through Large-Scale Experimental Validation
While an era is dawning in which artificial intelligence (AI) can rapidly design tens of thousands or even hundreds of thousands of antibodies, the designs produced by AI do not immediately become new…
Lifestyle
TG-C Failed to Clear U.S. Phase 3 Trials… Three Reasons Why Cartistem Is Confident
As Medipost begins full-scale Phase 3 clinical trials in the U.S. for “Cartistem,” a stem cell therapy for knee osteoarthritis, attention is focusing on its potential for success. Despite the clinical…
Disclosure Plus
Voronoi, Inc. Offers ‘30 Trillion Won M&A Success Bonus’ to Former Lilly CMO… The Math Behind the Unprecedented Stock Options
Voronoi, Inc.(310210)has granted its Chief Medical Officer (CMO), a former Eli Lilly executive, extraordinary stock options that can only be exercised if a change in control occurs when the company’s …
Business·Industry
[Noul Co., Ltd. Deep Seek ④] The Aftermath of an RP Agreement Made During a Rights Offering… 4 Million Shares Held by the Largest Shareholder Transferred to External Parties
MSEED, the largest shareholder of artificial intelligence (AI) diagnostics company Noul Co., Ltd.(376930), is facing repercussions from a repurchase agreement (RP) signed during its participation in a…
Business·Industry
DRTECH Surges on Return to Market; HLB Innovation and L&K Biomed Rise [K-bio pulse]
On September 10, DRTECH, which resumed trading following the completion of a reverse stock split, saw sharp swings in its share price. The medical imaging company drew investor attention as expectatio…
Lifestyle
DRTECH Corporation Draws Attention as Trading Resumes… HLB INC. and L&K BIOMED CO., LTD. Reflect Market Optimism [Bio Spotlight]
On the 10th, shares of DRTECH Corporation(214680), which resumed trading after completing a stock consolidation, experienced significant volatility in the pharmaceutical and biotech sector. DRTECH Cor…
Lifestyle
"Premium" in the U.S. and Europe, "Volume" in Shinhung… Value Added Technology Co., Ltd.’s "Two-Track" Strategy
Value Added Technology Co., Ltd.(043150)is accelerating its global growth through a “dual-track strategy”: raising average selling prices with premium products in developed markets while increasing sa…
Business·Industry
[Noul Co., Ltd. Deep Seek ③] The Looming Shadow of Another Stock Offering… Year-End Is the Crucial Moment
The shadow of another capital increase is looming over the artificial intelligence (AI) diagnostics company Noul Co., Ltd.(376930). Having raised approximately 25 billion won through a capital increas…
Technology
Lee Byung-hwan, CEO of SkyLabs: "In Discussions with Otsuka and U.S. Partners… Aiming for FDA Approval Next Year"
#SkyLabs is taking the final steps toward entering the U.S. market.Lee Byung-hwan, CEO of SkyLabs, met with E-Daily on the 7th and stated, “Since the cuffless continuous blood pressure monitor must go…
Lifestyle
'Loresibint Under Review for Approval in the U.K. Following U.S. Approval'… SamilPharmaceutical Gets Green Light to Enter 8 Trillion Won Korean Market
SamilPharmaceutical(000520)With “Lorecivivint,” a new drug for osteoarthritis for which BioSplice holds exclusive domestic distribution rights, entering the regulatory review process in the UK followi…